<DOC>
	<DOCNO>NCT02100943</DOCNO>
	<brief_summary>This study evaluate presence absence Obstructive Sleep Apnea ( OSA ) third trim pregnancy postpartum .</brief_summary>
	<brief_title>Exhaled NO Biomarker Gestational OSA Persistence Postpartum</brief_title>
	<detailed_description>This prospective cohort study evaluate presence absence OSA third trimester pregnancy postpartum . The investigator use Watch-PAT200® device accept standard diagnosis obstructive sleep apnea . When enrol , woman teach use Watch-PAT200® via company produce video show clinic available via YouTube review later need . They also complete Berlin Questionnaire . The patient use Watch-PAT200® device overnight evaluate obstructive sleep apnea . This perform 32-36 week gestation . Apnea-hypopnea index ( AHI ) calculate AHI &gt; 5 consider diagnostic OSA . The next morning patient return Watch-PAT200® device exhale NIOX MINO® ass exhale nitric oxide level . This perform 800-1000 one study personnel . The patient also wear Watch-PAT200® device first postpartum night . The entire process repeat 6-8 week postpartum .</detailed_description>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Female ( &gt; equal 18 year age ) Pregnant 32 0/7 prior 35 6/7 week gestation Anticipated delivery Forsyth Medical Center : Winston Salem , North Carolina Illicit drug/Alcohol abuse Current treatment obstructive sleep apnea Age &lt; 18 year Inability speak/read English proficiently enough give informed consent Usage alpha blocker short act nitrate Permanent pacemaker Sustained nonsinus cardiac arrhythmia</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Obstructive Sleep Apnea</keyword>
</DOC>